AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 295: H743-H754, 2008. First published June 13, 2008; doi:10.1152/ajpheart.00151.2008
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/H743    most recent
00151.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minneci, P. C.
Right arrow Articles by Gladwin, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minneci, P. C.
Right arrow Articles by Gladwin, M. T.

Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis

Peter C. Minneci,1,2,* Katherine J. Deans,1,* Sruti Shiva,3,4 Huang Zhi,3 Steven M. Banks,4 Steven Kern,4 Charles Natanson,4 Steven B. Solomon,4,* and Mark T. Gladwin3,4,*

1Department of Surgery, The Children's Institute for Surgical Science, The Children's Hospital of Philadelphia, Philadelphia; 2Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and 3Pulmonary and Vascular Medicine Branch, National Heart Lung and Blood Institute, and 4Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland

Submitted 12 February 2008 ; accepted in final form 28 May 2008

Hemoglobin (Hb) potently inactivates the nitric oxide (NO) radical via a dioxygenation reaction forming nitrate (NO3). This inactivation produces endothelial dysfunction during hemolytic conditions and may contribute to the vascular complications of Hb-based blood substitutes. Hb also functions as a nitrite (NO2) reductase, converting nitrite into NO as it deoxygenates. We hypothesized that during intravascular hemolysis, nitrite infusions would limit the vasoconstrictive properties of plasma Hb. In a canine model of low- and high-intensity hypotonic intravascular hemolysis, we characterized hemodynamic responses to nitrite infusions. Hemolysis increased systemic and pulmonary arterial pressures and systemic vascular resistance. Hemolysis also inhibited NO-dependent pulmonary and systemic vasodilation by the NO donor sodium nitroprusside. Compared with nitroprusside, nitrite demonstrated unique effects by not only inhibiting hemolysis-associated vasoconstriction but also by potentiating vasodilation at plasma Hb concentrations of <25 µM. We also observed an interaction between plasma Hb levels and nitrite to augment nitroprusside-induced vasodilation of the pulmonary and systemic circulation. This nitrite reductase activity of Hb in vivo was recapitulated in vitro using a mitochondrial NO sensor system. Nitrite infusions may promote NO generation from Hb while maintaining oxygen delivery; this effect could be harnessed to treat hemolytic conditions and to detoxify Hb-based blood substitutes.

blood flow; vascular endothelial function; blood substitute; vascular biology



Address for reprint requests and other correspondence: M. T. Gladwin, Pulmonary and Vascular Medicine Branch, National Heart, Lung, and Blood Institute, Critical Care Medicine Dept., Clinical Center, National Institutes of Health, Bldg. 10-CRC, Rm. 5-5140, 10 Center Dr., MSC 1454, Bethesda, MD 20892-1454 (e-mail: mgladwin{at}nih.gov)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
N. G Hord, Y. Tang, and N. S Bryan
Food sources of nitrates and nitrites: the physiologic context for potential health benefits
Am. J. Clinical Nutrition, July 1, 2009; 90(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. J. Kato and M. T. Gladwin
Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy
JAMA, December 10, 2008; 300(22): 2638 - 2646.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.